Wellness Clinical Research is pleased to recognize Principal Investigator Lucky Flores, MD, for his participation in the JADE COMPARE clinical trial.
PubMed lists Dr. Flores among the JADE COMPARE investigators associated with the New England Journal of Medicine publication, “Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.”
A phase 3 atopic dermatitis study
JADE COMPARE was a randomized, double-blind phase 3 trial in adults with moderate-to-severe atopic dermatitis. The study compared two doses of oral abrocitinib with dupilumab and placebo, with all participants receiving topical therapy.
The publication reported efficacy and safety outcomes across 838 randomized participants.
Dr. Flores listed among study investigators
The PubMed record includes a collaborator list for the JADE COMPARE Investigators and names Lucky Flores among those investigators.
The record provides a direct, public source confirming Dr. Flores’s participation in the trial investigator group.